PauwelsE., McCreadyV.R., StootJ., van DeurzenD.: The mechanism of tumour-localising radiopharmaceuticals. Eur J Nucl Med, 25: 277–305, 1998.
2.
VansteenkisteJ.F., StroobantsS.G.: The role of positron emission tomography with 18F-fluoro-2-deoxy-D-glucose in respiratory oncology. Eur Respir J, 17: 802–820, 2001.
3.
DelbekeD.: Oncological applications of FDG PET imaging. J Nucl Med, 40: 1706–1715, 1999.
4.
DelbekeD.: Oncological applications of FDG PET imaging: brain tumors, colorectal cancer, lymphoma and melanoma. J Nucl Med, 40: 591–603, 1999.
5.
StokkelM.P., DraismaA., PauwelsE.K.: Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma. J Cancer Res Clin Oncol, 127: 278–285, 2001.
6.
Van der HielB., PauwelsE.K., StokkelM.P.: Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas. J Cancer Res Clin Oncol, 127: 269–277, 2001.
7.
TurnerR.R., GiulianoA.E., HoonD.S., GlassE.C., KrasneD.L.: Pathologic examination of sentinel lymph node for breast carcinoma. World J Surg, 25: 798–805, 2001.
8.
NoguchiM.: Sentinel lymph node biopsy as an alternative to routine axillary lymph node dissection in breast cancer patients. J Surg Oncol, 76: 144–156, 2001.
9.
KragD., WeaverD., AshikagaT., MoffatF., KlimbergV.S., ShriverC., FeldmanS., KusminskyR., GaddM., KuhnJ., HarlowS., BeitschP.: The sentinel node in breast cancer – a multicenter validation study. N Engl J Med, 339: 941–946, 1998.
10.
PhelpsM.: PET: the merging of biology and imaging into molecular imaging. J Nucl Med, 41: 661–681, 2000.
11.
BlankenbergF.G., StraussH.W.: Will imaging of apoptosis play a role in clinical care? A tale of mice and men. Apoptosis, 6: 117–123, 2001.
12.
BlankenbergF., OhtsukiK., StraussH.W.: Dying a thousand deaths. Radionuclide imaging of apoptosis. Q J Nucl Med, 43: 170–176, 1999.
BlankenbergF.G., EckelmanW.C., StraussH.W., WelchM.J., AlaviA., AndersonC., BacharachS., BlasbergR.G., GrahamM.M., WeberW.: Role of radionuclide imaging in trials of antiangiogenic therapy. Acad Radiol, 7: 851–867, 2000.
15.
AronenH.J., PardoF.S., KennedyD.N., BelliveauJ.W., PackardS.D., HsuD.W., HochbergF.H., FischmanA.J., RosenB.R.: High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas. Clin Cancer Res, 6: 1189–1200, 2000.
16.
HustinxR., EckS., AlaviA.: Potential applications of PET imaging in developing novel cancer therapies. J Nucl Med, 40: 995–1002, 1999.
17.
FowlerJ.S., VolkowN.D., WangG.J., DingY.S., DeweyS.L.: PET and drug research and development. J Nucl Med, 40: 1154–1163, 1999.
